Overview
The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial
Status:
Completed
Completed
Trial end date:
2022-12-06
2022-12-06
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Will follow up umblical artery Doppler indices for pregnancies with iugr taking placebo and oral isosorbide mononitrate to study its efficacy on the intrauterine growth restricted fetusesPhase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Ain Shams UniversityTreatments:
Isosorbide
Criteria
Inclusion Criteria:- age : 18-34 BMI: 18-30 Singleton pregnancy Gestational age between 28-30 Criteria of
IUGR
Exclusion Criteria:
Had known or suspected chromosomal or structural anomaly Had a condition which will require
delivery Multiple pregnancy
-